TY  - GEN
AU  - Uhm,Joon H
AU  - Ballman,Karla V
AU  - Wu,Wenting
AU  - Giannini,Caterina
AU  - Krauss,J C
AU  - Buckner,Jan C
AU  - James,C D
AU  - Scheithauer,Bernd W
AU  - Behrens,Robert J
AU  - Flynn,Patrick J
AU  - Schaefer,Paul L
AU  - Dakhill,Shaker R
AU  - Jaeckle,Kurt A
TI  - Phase II evaluation of gefitinib in patients with newly diagnosed Grade 4 astrocytoma: Mayo/North Central Cancer Treatment Group Study N0074
SN  - 1879-355X
PY  - 2011///0701
KW  - Adult
KW  - Aged
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Brain Neoplasms
KW  - drug therapy
KW  - Chemotherapy, Adjuvant
KW  - methods
KW  - Dexamethasone
KW  - Diarrhea
KW  - chemically induced
KW  - Disease-Free Survival
KW  - Drug Administration Schedule
KW  - Enzyme Activators
KW  - ErbB Receptors
KW  - antagonists & inhibitors
KW  - Female
KW  - Gefitinib
KW  - Gene Amplification
KW  - genetics
KW  - Genes, erbB-1
KW  - Glioblastoma
KW  - Humans
KW  - In Situ Hybridization, Fluorescence
KW  - Male
KW  - Middle Aged
KW  - Quinazolines
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.ijrobp.2010.01.070
ER  -